HSDT
- Helius Medical Technologies, Inc.
()
Overview
Company Summary
Helius Medical Technologies, Inc. is a medical technology company that focuses on the development and commercialization of innovative neurological devices. The company specializes in non-invasive neuromodulation technologies, which means they create devices that stimulate the nervous system to modulate or change its activity without the need for surgery or invasive procedures.
The flagship product of Helius Medical Technologies is called the Portable Neuromodulation Stimulator (PoNS), which is a wearable device designed to treat chronic balance deficits caused by mild to moderate traumatic brain injuries (mTBI). This includes conditions like concussion and post-concussion syndrome. The PoNS device works in conjunction with targeted therapeutic exercises and is intended to enhance the brain's ability to relearn or rewire itself.
The core technology behind the PoNS device is called translingual neurostimulation (TLNS). It involves delivering mild electrical stimulation to the patient's tongue, which is then transmitted to the brain through the cranial nerves. This stimulation aims to promote neuroplasticity, the brain's ability to reorganize and form new connections, ultimately improving sensory and motor functions.
Helius Medical Technologies is also involved in various clinical research and development activities to explore the application of neuromodulation technologies in other neurological conditions and disorders. This includes multiple sclerosis, stroke rehabilitation, and cognitive enhancement.
In summary, Helius Medical Technologies develops and commercializes non-invasive neuromodulation technologies, primarily focusing on their PoNS device for the treatment of chronic balance deficits caused by mild to moderate traumatic brain injuries. They aim to improve patient outcomes by enhancing the brain's ability to rewire itself through neurostimulation.